Strategic partnerships Target potential collaborations with biogas and biofuel facilities, leveraging QBI's expertise in biomethane purification, anaerobic digestion, and customized biosensors to optimize production and quality control in renewable energy processes.

Process control Position QBI’s multiplexed biosensors and AI-driven data analytics as solutions for pharmaceutical and industrial process monitoring, offering real-time quality assurance, yield optimization, and compliance enhancements.

Custom assay offerings Highlight the ability to design customized immunoassays and single-domain antibodies (sdAbs/VHHs) for client-specific diagnostics, enabling faster assay development and niché market entry for customers with unique targets.

Strategic hiring leverage Leverage connections to QB3 and UC Berkeley leadership to co-create pilot programs or sponsored R&D initiatives, establishing credibility and opening doors to grant-funded collaborations and university-industry partnerships.

Funding and scale Approach potential investors and customers with QBI’s modest revenue alongside a clear path to scale through industrial partnerships, leveraging past funding and existing partnerships to de-risk large-scale deployments.